Public Health Action is the free access, online journal of The International Union Against Tuberculosis and Lung Disease. The journal focuses on TB, lung health, non-communicable diseases and related public health issues.

The International Journal of Tuberculosis and Lung Disease (IJTLD) is the official publication of the International Union Against Tuberculosis and Lung Disease (The Union).

The International AIDS Vaccine Initiative (IAVI) announced a social media fellowship starting the last week of January 2022.

Vice President Venkaiah Naidu on Thursday called on members of parliament and legislative assemblies and gram pradhans to conduct regular review meetings at district and sub-district levels to ensure a gender-sensitive approach to tuberculosis  eradication.

TB civil society and community groups, in partnership with national TB programs and others, have mapped and analyzed the evidence of human rights barriers to TB services in 20 countries across four regions.

The 6th Global Forum on TB Vaccines will be held on 22-24 February 2022 as a hybrid event, with options for in-person and virtual participation.

The COVID-19 pandemic hit South Africa’s TB response early and hard. To mitigate the impact of COVID-19 on TB, South Africa urgently needs to release the national TB Recovery Plan and the Department of Health should urgently implement steps outlined in the TB Recovery Plan to save lives.

TaBriX is a new spin-out company from The University of Manchester (UoM) with the mission to create novel anti-virulence drugs to fight difficult-to-treat infections. TaBriX’s initial focus is on the treatment of drug-resistant TB.

Scientists have spotted signs of ‘pre-resistance’ in bacteria for the first time – signs that particular bacteria are likely to become resistant to antibiotics in the future – in a new study led by UCL and Great Ormond Street Hospital researchers.

Achieving the goals and targets of the World Health Organization (WHO) End TB Strategy requires innovative tools and strategies as well as rapid progress towards universal access.